Related Articles
Mutation status of epidermal growth factor receptor and clinical features of patients with combined small cell lung cancer who received surgical treatment
Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines
Expression of c-kit (CD117) in neuroendocrine tumours - a target for therapy?
Secondary resistance to imatinib in patients with gastrointestinal stromal tumors through an acquired KIT exon 17 mutation
Acquired resistance to imatinib and secondary KIT exon 13 mutation in gastrointestinal stromal tumour